These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 3839006)
41. The capacity of activated murine macrophages for augmented binding of neoplastic cells: analysis of induction by lymphokine containing MAF and kinetics of the reaction. Marino PA; Adams DO J Immunol; 1982 Jun; 128(6):2816-23. PubMed ID: 6804569 [TBL] [Abstract][Full Text] [Related]
42. Activation of resident tissue-specific macrophages by swainsonine. Das PC; Roberts JD; White SL; Olden K Oncol Res; 1995; 7(9):425-33. PubMed ID: 8835286 [TBL] [Abstract][Full Text] [Related]
44. Comparison of the in vitro cytolytic effect of hepatic, splenic and peritoneal macrophages from glucan-treated mice on sarcoma M5076. Sherwood ER; Williams DL; Di Luzio NR Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):157-61. PubMed ID: 3713379 [TBL] [Abstract][Full Text] [Related]
45. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia. Li LH; Wallace TL; Richard KA; Tracey DE Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227 [TBL] [Abstract][Full Text] [Related]
46. The immunological basis of tumor rejection: the absolute dependence of the effector arm on sensitized T cells after chemoimmunotherapy of a murine sarcoma. Evans R; Duffy T J Immunol; 1985 Jun; 134(6):4255-60. PubMed ID: 3872913 [TBL] [Abstract][Full Text] [Related]
47. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing. Zhang L; Zhu H; Lun Y; Yan D; Yu L; Du B; Zhu X Cell Mol Immunol; 2007 Oct; 4(5):359-67. PubMed ID: 17976316 [TBL] [Abstract][Full Text] [Related]
48. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B. Kim H; Lee HS; Chang KT; Ko TH; Baek KJ; Kwon NS J Immunol; 1995 May; 154(9):4741-8. PubMed ID: 7536778 [TBL] [Abstract][Full Text] [Related]
49. Contrasting effects of activated and nonactivated macrophages and macrophages from tumor-bearing mice on tumor growth in vivo. Gabizon A; Leibovich SJ; Goldman R J Natl Cancer Inst; 1980 Nov; 65(5):913-20. PubMed ID: 6933261 [TBL] [Abstract][Full Text] [Related]
50. Immunomodulatory properties of recombinant murine and human tumor necrosis factor. Talmadge JE; Phillips H; Schneider M; Rowe T; Pennington R; Bowersox O; Lenz B Cancer Res; 1988 Feb; 48(3):544-50. PubMed ID: 3257167 [TBL] [Abstract][Full Text] [Related]
51. [The in vitro effect of silica fibers on macrophage-mediated cytotoxic activities in mice]. Yin L Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1989 Aug; 11(4):287-92. PubMed ID: 2558812 [TBL] [Abstract][Full Text] [Related]
52. Successful immunotherapy with intraperitoneal Corynebacterium parvum in a murine ovarian cancer model is associated with the recruitment of tumor-lytic neutrophils into the peritoneal cavity. Lichtenstein AK; Kahle J; Berek J; Zighelboim J J Immunol; 1984 Jul; 133(1):519-26. PubMed ID: 6373934 [TBL] [Abstract][Full Text] [Related]
53. Macrophages as effector cells in interleukin 12-induced T cell-dependent tumor rejection. Tsung K; Dolan JP; Tsung YL; Norton JA Cancer Res; 2002 Sep; 62(17):5069-75. PubMed ID: 12208763 [TBL] [Abstract][Full Text] [Related]
54. Activation of macrophage tumoricidal activity by photodynamic treatment in vitro--indirect activation of macrophages by photodynamically killed tumor cells. Reiter I; Schwamberger G; Krammer B J Photochem Photobiol B; 1999 Jun; 50(2-3):99-107. PubMed ID: 10515075 [TBL] [Abstract][Full Text] [Related]
55. Humoral regulation of cell-mediated immunity to syngeneic tumor. Ting CC Cancer Res; 1976 Oct; 36(10):3695-701. PubMed ID: 953995 [TBL] [Abstract][Full Text] [Related]
56. Enhancement of macrophage-induced cytotoxicity by phorbol ester tumor promoters. Laskin DL; Laskin JD; Kessler FK; Weinstein IB; Carchman RA Cancer Res; 1981 Nov; 41(11 Pt 1):4523-8. PubMed ID: 7306973 [TBL] [Abstract][Full Text] [Related]
57. Impaired anti-tumor cytotoxicity of macrophages from osteopontin-deficient mice. Bourassa B; Monaghan S; Rittling SR Cell Immunol; 2004 Jan; 227(1):1-11. PubMed ID: 15051510 [TBL] [Abstract][Full Text] [Related]
58. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro. Normann SJ; Cornelius J Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996 [TBL] [Abstract][Full Text] [Related]
59. Earthworm fibrinolytic enzyme: anti-tumor activity on human hepatoma cells in vitro and in vivo. Chen H; Takahashi S; Imamura M; Okutani E; Zhang ZG; Chayama K; Chen BA Chin Med J (Engl); 2007 May; 120(10):898-904. PubMed ID: 17543180 [TBL] [Abstract][Full Text] [Related]
60. Relationship of expression of A cell-surface antigen on activated murine macrophages to tumor cell cytotoxicity. Kaplan AM; Bear HD; Kirk L; Cummins C; Mohanakumar T J Immunol; 1978 Jun; 120(6):2080-5. PubMed ID: 659893 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]